December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Role of Factor V Leiden and Prothrombin 20210A in Retinal Artery Occlusion
Author Affiliations & Notes
  • M Weger
    Department of Ophthalmology Karl-Franzens University Graz Austria
  • W Renner
    Department of Internal Medicine Division of Angiology Karl-Franzens University Graz Austria
  • P Fellner
    Department of Ophthalmology Karl-Franzens University Graz Austria
  • O Stanger
    Department of Cardiac Surgery Atherothrombotic Research Group Karl-Franzens University Graz Austria
  • O Schmut
    Department of Ophthalmology Karl-Franzens University Graz Austria
  • A Haas
    Department of Ophthalmology Karl-Franzens University Graz Austria
  • Footnotes
    Commercial Relationships   M. Weger, None; W. Renner, None; P. Fellner, None; O. Stanger, None; O. Schmut, None; A. Haas, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 494. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M Weger, W Renner, P Fellner, O Stanger, O Schmut, A Haas; The Role of Factor V Leiden and Prothrombin 20210A in Retinal Artery Occlusion . Invest. Ophthalmol. Vis. Sci. 2002;43(13):494.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Retinal artery occlusion is a common vision threatening disease. Among other risk factors, coagulopathies leading to a hypercoagulable state have been associated with retinal artery occlusion. Numerous studies have shown that factor V Leiden and prothrombin 20210A cause a procoagulant state. However, their role in the pathogenesis of retinal artery occlusion is still unclear. The purpose of the present study was therefore to investigate a possible association between factor V Leiden, prothrombin 20210A and retinal artery occlusion. Methods: In the present retrospective case-control study we studied 107 patients with retinal artery occlusion and 107 age and gender matched control subjects. Genotypes of factor V Leiden and prothrombin 20210A were determined by polymerase chain reaction. Results: The prevalences of the heterozygous genotype for prothrombin 20210A did not significantly differ between patients and controls (3 patients vs. 2 controls). No significant difference in the distribution of factor V Leiden genotypes could be observed among patients and controls (heterozygous genotype: 8 patients vs. 10 controls). As for other risk factors, arterial hypertension and a history of stroke were significantly more frequent in patients than in controls (arterial hypertension: 68 patients vs.47 controls, p=0.006; stroke: 18 patients vs. 4 controls, p=0.001). Conclusion: We therefore conclude that factor V Leiden and prothrombin 20210A do not play a major role in patients with retinal artery occlusion.

Keywords: 615 vascular occlusion/vascular occlusive disease • 420 genetics • 480 mutations 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×